Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity Advisor® Mid Cap Value Fund Class T (FMPTX)

23.30
Net Asset Value
+2.60%
1 Day
-4.12%
Year-to-Date
Overall Morningstar Rating
Mid-cap value
Style or Category
3.5
Sales Expenses
1.44%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of companies with medium market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell Midcap  Index or the S&P MidCap 400  Index). It invests in companies with smaller or larger market capitalizations. The fund invests in domestic and foreign issuers.

Performance

1 month-3.68% 3 years+17.70%
3 months-8.41% 5 years+16.29%
1 year+1.60% Since inception+7.01%
Data through --

Peer Comparisonvs. Mid-cap value

 FMPTXCategory
Performance 5-yr return+16.29%+16.08%
Expense ratio1.44%1.23%
Risk 5 year sharpe ratio1.191.03
Net assets$4.0B$1.8B
Average market cap$13.2B$8.9B
Average P/E16.417.9
Portfolio turnover69%69%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureCourt Dignan / 2 Years
Minimal initial investment$2,500.00
Minimum IRA investment$500.00

Holdings

U.S. stock91.86%
International stock5.74%
Cash2.40%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 29.20%
Energy 13.85%
Consumer goods 13.05%
Industrial materials 12.79%
Utilities 10.74%
Top 10 Holdings
Portfolio weighting
COF Capital One Financial1.95%
CF CF Industries Holdings Inc1.93%
DFS Discover Financial Services1.88%
BX Blackstone Group1.60%
ALL Allstate1.57%
NRF Northstar Realty Finance Corp1.56%
ELS Equity LifeStyle Properties Inc1.45%
EXC Exelon1.42%
PEG Public Service Enterprise Group Inc1.42%
TEVA Teva Pharmaceutical1.37%

Partner Offers